All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly April 11, 2025

➤ NDA submitted to the FDA for presbyopia drop ➤ FDA issues complete response letter to dry eye NDA ➤ FDA accepts BLA resubmission for bevacizumab to treat wet AMD ➤ One-month results in Phase 1/2 trial for treating Leber congenital amaurosis in a pediatric patient ➤ ASCRS news and events

Comments Off on EyeWorld Weekly April 11, 2025

EyeWorld Weekly, March 7, 2025

➤ Proof-of-concept trial for intravitreal implant for glaucoma patients ➤ Phase 3 study evaluating intravitreal gene therapy for wet AMD ➤ New analysis shows differentiation of investigational glaucoma treatment ➤ IND studies to investigate gene therapy for dry AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 7, 2025

EyeWorld Weekly, January 24, 2025

➤ Fast Track Designation granted for investigational retinitis pigmentosa therapy ➤ Three-month data for first-in-class dual inflammasome inhibitor for geographic atrophy ➤ Clinical updates for sustained-release drug implant treating glaucoma ➤ Gene therapy program receives Rare Pediatric Disease Designation ➤ Study: lasting effect of multifocal contact lenses for myopia progression ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, January 24, 2025

EyeWorld Weekly, December 20, 2024

➤ Positive topline data in Phase 1/2 allogenic cell therapy trial ➤ Investigational, light-based treatment for infectious keratitis ➤ Topline results from Phase 3 clinical trial for chronic thyroid eye disease ➤ Primary endpoint met in trial investigating extended dosing interval for retinal vein occlusion treatment ➤ Rare Pediatric Disease Designation granted to investigational retina gene therapy ➤ Merger and acquisition news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, December 20, 2024

Culture of safety: a microbiological assessment of reusable instruments

In this issue’s column, the authors discussed the surgical work of ophthalmologists at Aravind Eye Hospital in India. They shared the results of the standardized protocols that include reusing devices for cataract surgery usually deemed single use in Western countries.

Comments Off on Culture of safety: a microbiological assessment of reusable instruments

Allergies or intolerance to materials used in cataract surgery

While true allergies to materials used during cataract surgery are uncommon, this is a topic that physicians may need to discuss with patients. Two physicians highlighted some of the key concerns they hear from patients and how they approach these to identify real allergies versus intolerances.

Comments Off on Allergies or intolerance to materials used in cataract surgery

Latest lessons learned with the Light Adjustable Lens

With its approval in 2017, many physicians have several years of lessons learned with the Light Adjustable Lens (LAL, RxSight). With the more recent commercial launch of the LAL+, which has a modified aspheric surface to extend depth of focus slightly, ophthalmologists have even more to talk about.

Comments Off on Latest lessons learned with the Light Adjustable Lens

EyeWorld Weekly, December 13, 2024

➤ Topline results for non-steroidal immunomodulator for postop inflammation ➤ Pilot study describes use of prosthetic device for treatment of dry eye ➤ First patient dosed in Phase 3 trial investigating wet AMD treatment ➤ Acquisition and partnership news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, December 13, 2024

How to talk to patients about IOL options

With great opportunity in the world of IOLs also comes a challenge: how to discuss these options efficiently in a targeted manner without overwhelming or causing confusion for the patient. EyeWorld spoke with three members of its Cataract Editorial Board to learn how they manage this discussion.

Comments Off on How to talk to patients about IOL options